ADVM
Adverum Biotechnologies Inc.
$3.08
+$0.05(+1.65%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$66.31M
Volume
65.63K
52W Range
$1.78 - $8.56
Target Price
$19.75
EPS Estimates Overview
| Current Quarter | $-1.64 | Next Quarter | $-0.58 |
| Current Year | $-5.88 | Next Year | $-3.45 |
| QoQ Growth | +64.6% | YoY Growth | +41.3% |
| 3Y EPS CAGR | -45.4% | Target Price | $19.75 |
| Consensus | Buy | Upside | +541.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADVM | $3.08 | +1.7% | 65.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adverum Biotechnologies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW